ESLA · Estrella Immunopharma, Inc.

NasdaqHealthcareBiotechnology

Estrella Immunopharma Inc Is A Clinical-Stage Biopharmaceutical Company. The Company Is Engaged In Developing Cd19 And Cd22-Targeted Artemis T-Cell Therapies With The Capacity To Address Treatment Challenges For Patients With Blood Cancers And Solid Tumors.

HealthcareNasdaqUSMid Float

$2.08

+103.9% latest move

Price & move as of the most recent catalyst (Jun 2) — not a live quote.

FLOAT

15.1M

FREE FLOAT %

35%

SHARES O/S

43.5M

MARKET CAP

$14.3M

EXCHANGE

Nasdaq

COUNTRY

ESLA Catalyst History

Financial ResultsJun 2, 2025 · 7:07pm ET

ESLAEstrella Immunopharma, Inc. Common Stock

Estrella Immunopharma Announces Private Placement Financing

Estrella Immunopharma, Inc. has announced a private placement equity financing.

Be early on the next ESLA spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →